Effects of Ruangan Huajian granule on hepatic expression of α-SMA, TGFβ1, and COL-Ⅰ in C57 mice with experimental hepatic fibrosis
Objective To observe the effect of Ruangan Huajian granule on hepatic expression of alpha-smooth muscle actin (α-SMA) , tumor growth factor-beta 1 (TGFβ1) , and collagen I (COL-Ⅰ) using a C57 mouse model of experimental hepatic fibrosis.Methods Forty C57 mice were randomly divided into four groups (n=10 each) : uninduced normal control group, model control group, model treatment group with low-dose (0.1 g/day for six weeks) Ruangan Huajian granule, model treatment group with high-dose (0.2 g/day for six weeks) Ruangan Huajian granule.Hepatic fibrosis was induced by intraperitoneal injection of 10% carbon tetrachloride.The expression of α-SMA, TGFβ1, and COL-Ⅰ in liver tissue of mice was observed by immunohistochemistry.The liver tissues were also scored for fibrosis stage by evaluating morphological changes detected upon hematoxylin-eosin and Masson trichrome staining.Results There were significantly higher levels of α-SMA, TGFβ1, and COL-Ⅰ expression and scores of fibrosis stage in the hepatic fibrosis mice than in the normal control mice (P<0.05) and in the model control group than in either the low-dose or high-dose model treatment groups (P<0.05) .there="" was="" no="" significant="" difference="" between="" the="" low-dose="" model="" treatment="" group="" and="" high-dose="" p="">0.05) .Conclusion Ruangan Huajian granule may alleviate the degree of fibrosis in C57 mice with experimental hepatic fibrosis by reducing hepatic expression of α-SMA and TGFβ1.Furthermore, Ruangan Huajian granule may depress hyperplasia by reducing COL-Ⅰ expression.
[1] 高啸, 郭燕, 刘红艳, 等.血吸虫性肝纤维化小鼠肝组织中内源性大麻素受体1的表达[J].中华肝脏病杂志, 2007, 15 (5) :389-390.
|
[2]英嵩崧, 李旭, 黄茂梁, 等.血管紧张素1-7对大鼠肝星状细胞α-平滑肌肌动蛋白表达的影响[J].南方医科大学学报, 2009, 29 (4) :732-734.
|
[3]阳丹才让, 邓勇, 任利, 等.硫化氢在大鼠肝星状细胞氧应激中对α-SMA与细胞周期影响的实验研究[J].现代生物医学进展, 2010, 10 (12) :2205-2208.
|
[4]李志刚, 杨晋翔, 张伟, 等.肝心宁对大鼠肝纤维化α-SMA, MMP-13及TIMP-1蛋白表达的影响[J].北京中医药大学学报 (中医临床版) , 2009, 16 (5) :6-9.
|
[5]李晓荟, 姜树军, 李佃贵.化浊软坚汤对免疫性肝纤维化模型大鼠TGF-β1表达的影响[J].山东中医药大学学报, 2010, 34 (2) :173-175.
|
[6]徐珊, 包剑峰, 周敏, 等.肝纤维化不同证型与TGF-β1/Smad基因蛋白表达关系的实验研究[J].中华中医药学刊, 2010, 28 (1) :23-25.
|
[1] | Xiwang WANG, Jingjing JIN, Ying WANG, Chenxiao WANG, Yonghua ZHANG, Yajiao GU, Xiao WANG. Pathogenesis, diagnosis, and treatment of pancreatogenic diabetes[J]. Journal of Clinical Hepatology, 2024, 40(5): 1068-1072. doi: 10.12449/JCH240532 |
[2] | Ruibin WANG, Yuzheng LU, Jinglin ZHU, Wei WANG, Guang JIA. Inhibitory effect of lidocaine on Kupffer cell inflammatory response and its effect on liver abscess formation in diabetic mice[J]. Journal of Clinical Hepatology, 2022, 38(6): 1341-1346. doi: 10.3969/j.issn.1001-5256.2022.06.023 |
[3] | Deyun WANG, Ruirui JIN, Zhen ZHAO, Hui LI. Brain abscess secondary to liver abscess in type 2 diabetes mellitus: A case report[J]. Journal of Clinical Hepatology, 2022, 38(6): 1375-1376. doi: 10.3969/j.issn.1001-5256.2022.06.031 |
[4] | Changqing ZHAO. Integrated traditional Chinese and Western medicine diagnosis and treatment of liver cirrhosis with diabetes[J]. Journal of Clinical Hepatology, 2022, 38(9): 1980-1985. doi: 10.3969/j.issn.1001-5256.2022.09.006 |
[5] | Zhao Juan, Hui Wei, Dou AiHua, Wei LinLin, Liu Mei, Dong GuiFang, Xu Bin. A clinical analysis of hypoglycemia in patients with liver cirrhosis and diabetes mellitus[J]. Journal of Clinical Hepatology, 2020, 36(2): 329-332. doi: 10.3969/j.issn.1001-5256.2020.02.019 |
[6] | Zhang YongChao, Li Wei. Association between diabetes and nonalcoholic fatty liver disease-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(10): 2329-2332. doi: 10.3969/j.issn.1001-5256.2020.10.037 |
[7] | Wang WeiZhao, Zhu QinLing, Xiang XiaoXing, Ma Li, Ju MengXian, Jin XiaoLong, Wang YongChao, Han WeiWei, Xu QingCheng. Clinical features of diabetic patients with bacterial liver abscess and different levels of glycosylated hemoglobin[J]. Journal of Clinical Hepatology, 2019, 35(11): 2537-2541. doi: 10.3969/j.issn.1001-5256.2019.11.029 |
[8] | Zhang ShuZe, Wang KeShen, Ren YanXian, Yu ZeYuan, Yang HanTeng, Jiao ZuoYi. Clostridium perfringens liver abscess in patients with diabetes mellitus: A case report[J]. Journal of Clinical Hepatology, 2018, 34(9): 1979-1981. doi: 10.3969/j.issn.1001-5256.2018.09.030 |
[9] | Yang Shuo, Jiang XiaoDi. Clinical effect of linagliptin combined with insulin aspart 50 in treatment of hepatogenous diabetes[J]. Journal of Clinical Hepatology, 2017, 33(5): 928-931. doi: 10.3969/j.issn.1001-5256.2017.05.028 |
[10] | Liang Jing, Han Tao. Diabetes mellitus and primary liver cancer: risk factor or real cause?[J]. Journal of Clinical Hepatology, 2017, 33(4): 757-762. doi: 10.3969/j.issn.1001-5256.2017.04.037 |
[11] | Wang LiFeng, Li YuanYuan, Jin Lei, Wang FuSheng. Epidemiology and natural history of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 165-170. doi: 10.3969/j.issn.1001-5256.2015.02.005 |
[12] | Liu HongXia, Cheng Min, Wang XiMing, Lei Ding. Clinical effect of combination therapy with NovoRapid 30 and modified Yinchenhao decoction in treatment of chronic hepatitis B with diabetes[J]. Journal of Clinical Hepatology, 2014, 30(4): 311-313. doi: 10.3969/j.issn.1001-5256.2014.04.006 |
[13] | Hui Wei, Xu Bin, Guo XinHui. Clinical study on glucose metabolic disorder in patients with diabetes and chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(7): 538-541. |
[14] | Zhao ZhangQing, Gu HongTu, Xing Feng, Zhou Yang, Xu LieMing. Clinical features of post-hepatitis B liver cirrhosis associated with diabetes mellitus[J]. Journal of Clinical Hepatology, 2012, 28(6): 450-455. |
[15] | Zhang FengChun. Primary biliary cirrhosis and liver disease secondary to diffuse connective tissue diseases[J]. Journal of Clinical Hepatology, 2011, 27(6): 588-590. |
[16] | Yu MingXia, Yin WeiMin, Li YingJin, Wu Yang. The treatment status of hepatogenous diabetes[J]. Journal of Clinical Hepatology, 2011, 27(7): 779-782. |
[20] | Qin YingFen, Xian Su, Wei MinYi, Luo ZuoJie, Chen QingYun, Wang NaiZun. Changes of hepatic ultrastructure in patients with diabetes mellitus[J]. Journal of Clinical Hepatology, 2000, 16(4): 241-243. |